BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome

Conditions:   Stroke, Ischemic;   Coronary Artery Disease;   Angina Pectoris, Stable;   Diabetic Peripheral Neuropathy Interventions:   Drug: Buqitongluo Granule;   Drug: Buqitongluo Granule Placebo;   Other: Standard care Sponsors:   Dongzhimen Hospital, Beijing;   The Affiliated Hospital of Changchun University of Chinese Medicine;   The Affiliated Hospital of Shandong University of Chinese Medicine;   The Affiliated Hospital of Chengdu University of Chinese Medicine;   The Second Affiliated Hospital of Tianjin Univer sity of Traditional Chinese Medicine;   The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine;   The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine;   The Second Affiliated Hospital of Hunan University of Traditional Chines e Medicine;   Hunan Academy of Traditional Chinese Medicine Affiliated Hospital;   The First Clinical Hospital of Jilin Academy of Traditional Chinese Medicine;   Shaanxi Buchang Pharmaceuticals Co., Ltd.;   Beijing Chuanglikechuang Medical Technology Development Co., Ltd.;   Shanghai Youn ingwei Biotechnology Co., Ltd.;   Wuhan Zhizhi Medical Technology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials